CVS vs HUM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
CVS
HUM
Investment Advisor Scores
HUM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CVS | HUM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10.0806 | 26.5252 | CVS |
| PEG Ratio | 0.2078 | 1.1663 | CVS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.4% | 26.1% | HUM |
| Earnings Growth | 188.8% | -17.9% | CVS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 63.1/100 | 44.3/100 | CVS |
| Profit Margin | 2.6% | 0.8% | CVS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | HOLD | CVS |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CVS
NeutralMixed signals - no dominant trend phase, RSI 52
HUM
MarkupPrice above SMA50, rising 50-day trend (3.8% over 20 days), RSI 62
Fundamentals Snapshot
| Metric | CVS | HUM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.4 | 25.5 |
| Trailing P/E | 10.4 | 43.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.3% |
| Gross Margin | 0.1% | 0.1% |
| Operating Margin | 0.0% | 0.0% |
| EPS | 8.61 | 10.25 |
| Dividend Yield | 0.03% | 0.01% |